Мова NL EN DE ES FR UK IT

Аналіз перебудови

Аналіз мереж

Чиста база для мережевого аналізу депутатів ЄП, документів і тем. Жодних жорстких політичних ярликів, лише перевірювані докази.

You are here

VERSLAG over het genderperspectief in de COVID-19-crisis en de periode na de crisis

You are viewing a dossier. From here you can see which actors, signals and linked vote events are visible around this document.

Jump to

Dossier Actors Sources and context Supporting layers Linked vote events

Dossier

VERSLAG over het genderperspectief in de COVID-19-crisis en de periode na de crisis

Verslag voor de plenaire vergadering van het EP | 2020-11-20 | source: plenary_documents

Open bronpagina Leesbare metadata Wikipedia zoeken

Pfizer en covid
1Actors
1Signals
9EP term
Sources and context Source text and aggregated content + Provenance and audit

Source text and aggregated content

VERSLAG over het genderperspectief in de COVID-19-crisis en de periode na de crisis
P9_A(2020)0229

Provenance and audit

This block makes visible which source layer and datapoints the current view is based on.

Source layer plenary_documents
Canonical identifier A-9-2020-0229
Official source URL https://data.europarl.europa.eu/eli/dl/doc/A-9-2020-0229
Title and language layer Only Dutch title available
EP term 9

News context around this event

Use these links to quickly search reputable news sources around the event date using the title and keywords.

Search period: 2020-11-20
Keywords: het genderperspectief in de COVID-19-crisis en de periode na de crisis
Reuters Financial Times Politico Europe The Guardian NRC de Volkskrant Google News
Supporting layers Signals

Signals

topic-match / pfizer-covid

Value: 0.8000

VERSLAG over het genderperspectief in de COVID-19-crisis en de periode na de crisis P9_A(2020)0229 Frances FITZGERALD; FEMM

Linked vote events Votes and seat distribution

Linked vote events

No official vote items linked to this dossier yet.

Next logical step

Use these routes to continue your research from this page.

Continue to topics Continue to evidence board Back to dashboard